Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore · Delayed Price · Currency is SGD 0.0290
+0.0020 (7.41%)
At close: Sep 11, 2026
SGXC:9G2 Balance Sheet
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 15.18 | 2.84 | 3.16 | 11.05 | 15.84 |
Short-Term Investments | - | 0.54 | 0.04 | 0.25 | 0.27 |
Cash & Short-Term Investments | 15.18 | 3.38 | 3.21 | 11.3 | 16.11 |
Cash Growth | 348.87% | 5.45% | -71.62% | -29.86% | 53.32% |
Accounts Receivable | 2.47 | 1.43 | 0.94 | 1.46 | 1.6 |
Other Receivables | - | 0.17 | 0.17 | 0.29 | 2.41 |
Receivables | 2.47 | 1.59 | 1.12 | 1.74 | 4.01 |
Inventory | 0.11 | 0.11 | 0.1 | 0.11 | 0.1 |
Prepaid Expenses | - | 0.22 | 0.23 | 0.26 | 0.12 |
Other Current Assets | 0.41 | 0 | 0.01 | 0.03 | 0.26 |
Total Current Assets | 18.17 | 5.31 | 4.66 | 13.44 | 20.59 |
Property, Plant & Equipment | 110.31 | 116.19 | 130.41 | 142.1 | 138.24 |
Other Intangible Assets | 0 | 0.01 | 0.02 | 0.03 | 0.04 |
Long-Term Accounts Receivable | - | - | - | - | 0.06 |
Other Long-Term Assets | 3.62 | 3.2 | 3.67 | 3.95 | 15.43 |
Total Assets | 132.1 | 124.71 | 138.76 | 159.52 | 174.36 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 12.67 | 0.61 | 0.58 | 0.76 | 0.46 |
Accrued Expenses | - | 3.28 | 3.88 | 5.08 | 17 |
Short-Term Debt | - | 5.13 | - | 1.9 | 4.04 |
Current Portion of Long-Term Debt | 18.85 | 4.34 | 3.82 | 22.81 | 15.27 |
Current Portion of Leases | 3.21 | 1.78 | 2.63 | 2.49 | 2.28 |
Current Unearned Revenue | - | 0.24 | 0.15 | 0.25 | 0.02 |
Other Current Liabilities | - | 1.97 | 1.48 | 19.64 | 11.06 |
Total Current Liabilities | 34.73 | 17.35 | 12.54 | 52.94 | 50.13 |
Long-Term Debt | 10.87 | 18.79 | 9.69 | 21.12 | 29.92 |
Long-Term Leases | 28.36 | 28.18 | 29.96 | 32.45 | 35.79 |
Other Long-Term Liabilities | 5.23 | 4.76 | 4.82 | 8.09 | 4.46 |
Total Liabilities | 79.18 | 69.07 | 57.01 | 114.6 | 120.31 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 209.33 | 191.46 | 190.86 | 104.84 | 102.55 |
Retained Earnings | -154.64 | -130.75 | -103.69 | -66.25 | -48.18 |
Comprehensive Income & Other | -1.77 | -5.08 | -5.43 | 6.33 | -0.32 |
Shareholders' Equity | 52.92 | 55.64 | 81.74 | 44.93 | 54.05 |
Total Liabilities & Equity | 132.1 | 124.71 | 138.76 | 159.52 | 174.36 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 61.28 | 58.21 | 46.1 | 80.77 | 87.3 |
Net Cash (Debt) | -46.1 | -54.83 | -42.89 | -69.48 | -71.19 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.05 | -0.05 | -0.10 | -0.11 |
Filing Date Shares Outstanding | 1,724 | 1,062 | 1,048 | 893.83 | 645.16 |
Total Common Shares Outstanding | 1,724 | 1,062 | 1,048 | 337.99 | 645.16 |
Working Capital | -16.55 | -12.03 | -7.89 | -39.5 | -29.53 |
Book Value Per Share | 0.03 | 0.05 | 0.08 | 0.13 | 0.08 |
Tangible Book Value | 52.92 | 55.63 | 81.73 | 44.9 | 54.02 |
Tangible Book Value Per Share | 0.03 | 0.05 | 0.08 | 0.13 | 0.08 |
Machinery | - | 77.25 | 77.9 | 77.66 | 72 |
Construction In Progress | - | - | - | - | 42.94 |